Skip to main content

Table 7 Residual tumor TNM staging according to AJCC classification

From: Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial

Group

TNM Definition

Stage

0

IA

IB

IIA

IIB

IIIA

IIIB

IIIC

Control

n (%)

Anatomical

0

2 (7.4)

3 (11.0)

8 (29.6)

2 (7.4)

0

2

2 (7.4)

Prognostic

0

2 (7.4)

0

7 (25.9)

2 (7.4)

5 (18.5)

1 (3.7)

2 (7.4)

Intervention

n (%)

Anatomical

2 (8.0)

1 (4.0)

2 (8.0)

6 (24.0)

0

3 (12.0)

5 (20.0)

0

Prognostic

2 (8.0)

1 (4.0)

0

4 (16.0)

1 (4.0)

8 (32.0)

0

3 (12.0)

  1. AJCC American joint committee on cancer
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us